Transcend Medical Sees $51M

Menlo Park-based Transcend Medical, which is developing opthalmic devices for treating glaucoma, has raised $51M in its Series B round, the firm said this week. The new funding came as part of a second tranche in the Series B round. The firm's investors now include Investor Growth Capital, a new investor in the company, along with existing investors Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. Transcend Medical is a spinout of ForSight Labs. More information »